Kymera Therapeutics Trades Flat Near 81 as Biotechnology Sector Awaits Catalysts India Inc Gets New CSR Avenue Zero Coupon Zero Principal Instrument Allows Up to 10 Allocation LEGN Q1 2026 Earnings Staggering EPS Shortfall Highlights Cost Pressures Triveni Engineering Q4 Profit Declines FullYear Performance Shows Growth Amid Amalgamation